Founded in 1929 in Barcelona, Reig Jofre is a family-controlled pharmaceutical company listed on the Spanish Stock Exchange’s continuous market and dedicated to the research, development, manufacture and marketing of pharmaceutical products and nutritional supplements from its four plants in Toledo (2), Barcelona and Malmö (Sweden).
Reig Jofre structures its product development activity in three business areas:
- Pharmaceutical technologies specialized in sterile and lyophilized injectables, and antibiotics derived from penicillin
- Specialty Pharmacare in dermatology; Joint Pain, and Women’s Health
- Consumer Healthcare, with products aimed at the consumer under the Forté Pharma brand, mainly in France, Belgium, Spain and Portugal, and other OTCs.
Reig Jofre has more than 1,100 employees, direct sales in 7 countries and more than 130 business partners in 72 countries around the world. The company closed 2019 with a turnover of 200 million Euros.
Reig Jofre is listed the ticker RJF.